Asalkii hore
Fayraska Hantaan (HV) waa cudur-sidaha aasaasiga ah ee ka mas'uulka ah Qandhada Dhiig-baxa ee qaba Cudurka Kelyaha (HFRS). HFRS waa cudur faafa oo ba'an oo caalami ah loo qaybiyey zoonotic oo lagu garto qandho, dhiigbax, iyo kelyo daciif ah. Cudurku wuxuu leeyahay bilow degdeg ah, horumar degdeg ah, iyo heerka dhimashada oo sarreeya, oo khatar weyn ku ah caafimaadka bulshada. Jiirka (sida Apodemus agrarius iyo Rattus norvegicus) waa kaydadka ugu muhiimsan iyo xididada HV. Gudbinta bini'aadamka waxay ku dhacdaa inta ugu horaysa iyada oo loo marayo saxarada hawada hawada ku jirta ( kaadida, saxarada, candhuufta), taabashada tooska ah, ama qaniinyada vector. HFRS waxay dhici kartaa sanadka oo dhan, dadweynaha guudna waa u nugul yihiin. Marka loo eego tirakoobka WHO, 32 waddan oo adduunka oo dhan ah ayaa soo sheegay dillaaca HV, oo si gaar ah ugu baahay Bariga Aasiya, Yurub, iyo Balkans-ka.
Calaamadaha Kahortagga Dhiiga Ka Dib Caabuqa HV
Infekshanka HV ka dib, habka difaaca bani'aadamku wuxuu soo saaraa unugyo gaar ah, oo ay ugu horreeyaan HV-IgM iyo HV-IgG.
● unugyada difaaca jirka ee HV-IgM: U adeega sida calaamada serological ee infekshanka hore, oo caadi ahaan soo baxa maalmo gudahooda calaamaduhu, waxayna muhiim u yihiin ogaanshaha wajiga degdega ah.
● unugyada difaaca jirka ee HV-IgG: Hadhow soo baxa waxaana laga yaabaa inay sii jiraan nolosha, taasoo muujinaysa caabuq hore ama bogsasho. Korodhka afar laab ama ka weyn ee HV-IgG antibody titer inta u dhaxaysa shaybaarada serum ba'an iyo convalescent sidoo kale waa ogaanshaha caabuqa degdega ah.
Hababka Baadhista HV ee Caadiga ah
Hababka shaybaadhka hadda ee lagu ogaanayo HV waxaa ka mid ah go'doominta fayraska, PCR, ELISA serological, iyo imtixaannada difaaca jirka ee kolloidal gold.
● Dhaqanka fayraska iyo PCR waxay bixiyaan tilmaamo sare laakiin waqti badan ayay qaataan, farsamo ahaan u baahan yihiin, waxayna u baahan yihiin tas-hiilaad shaybaar oo horumarsan, xaddidaya isticmaalkooda baahsan.
● Micro-immunofluorescence (MIF) waxay bixisaa saxnaan wanaagsan laakiin waxay u baahan tahay mikroskoob-fuloorescence iyo fasiraad khabiir, xaddidaya codsiga caadiga ah.
● ELISA iyo shaybaarrada dahabka kolloidhka ah ayaa si weyn looga qaataa goobaha caafimaadka iyadoo ay ugu wacan tahay fudaydnimadooda, xawligooda, dareenkooda sare iyo gaar ahaantooda, iyo sahlanaanta ururinta muunada (serum/plasma).
Waxqabadka Alaabta
Beier Bio's HV-IgM/IgG (ELISA) Tilmaamaha Qiimaynta
● Tusaalaha Nooca: Serum, Plasma
● Tusaalaha Dilution: IgM iyo IgG assays labaduba waxay isticmaalaan muunad si fiican u asal ah oo leh 1:11 dilution (100µl muunad dareere ah + 10µl muunad), hagaajinta socodka shaqada iyo yaraynta culeyska shaqada
● Reagent Diyaar u ah in la Isticmaalo: Dhammaan reagen-yaasha waa diyaar marka laga reebo bakheeyaha dhaqda (20× xooga saaray). Midab-codeed si fudud loo aqoonsan karo
● Habka kicinta: 30 min / 30 min / 15 min; si buuxda u toosan
● Dhererka Mawjada: 450 nm oo leh tixraac 630 nm
• Xariijimaha Dahaarka leh: 96 ama 48 ceel la jabin karo, mid walbana leh koodka alaabada daabacan ee raadraaca iyo ku habboonaanta
Beier Bio's HV-IgM/IgG (Dahab Colloidal) Assay Assay
Nooca Tusaalaha: Serum
Waqtiga ogaanshaha: Natiijooyinka 15 daqiiqo gudahood; qalab dheeraad ah looma baahna; ku habboon in si degdeg ah loo baaro bukaan-socodka, xaaladaha degdegga ah, iyo goobaha bukaannada ee kala firirsan
Habka: Ku dar 10µl muunada muunada kaadhka tijaabada si fiican adiga oo isticmaalaya dhibco; ku turjunto natiijada 15-20 daqiiqo gudahood
Waxqabadka Caafimaad ee HV-IgM (ELISA), HV-IgG (ELISA), iyo HV-IgM/IgG (Dahab Colloidal)
| PMagaca dhabta ah | HV-IgM (ELISA) | HV-IgG (ELISA) | HV-IgM (Dahab Colloidal) | HV-IgG (Dahab Colloidal) |
| Dareenka bukaan socodka | 99.1% 354/357 | 99.0% 312/315 | 98.0% 350/357 | 99.1% 354/357 |
| Gaar ahaanshaha Clinical | 100% 700/700 | 100% 700/700 | 100% 700/700 | 99.7% 698/700 |
Waqtiga boostada: Nov-11-2025
